Literature DB >> 20628765

[Types of topical treatment for peripheral neuropathic pain : Mechanism of action and indications].

R Baron1, F Mahn.   

Abstract

The term "peripheral neuropathic pain syndromes" summarizes several chronic pain syndromes, which can occur focally or generalized in the peripheral nervous system in the course of an impairment of afferent neurons. Controlled clinical trials gave distinct indications for systemic treatments with antidepressants, anticonvulsants and opioid analgesics in several neuropathic pain syndromes. In addition to these systemic therapies, there are also two topical treatment options: topical application of lidocaine and capsaicin. An important cause of sensitization phenomena of afferent nociceptors is the upregulation of sodium channels and thermosensor channels. In the context of a partial nerve lesion that leaves behind partially preserved or regenerated afferent nerve fibres, just these channels could be used as target structures for topical medications. Topically applied drugs are absorbed systemically only in minute quantities, so systemic side effects are negligible. Pharmacological interactions with systematically acting substances are also virtually absent; thus, topically applied substances are especially appropriate for add-on therapy in addition to systemic pain medication.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20628765     DOI: 10.1007/s00482-010-0939-6

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  47 in total

Review 1.  The role of voltage-gated sodium channels in neuropathic pain.

Authors:  Josephine Lai; John C Hunter; Frank Porreca
Journal:  Curr Opin Neurobiol       Date:  2003-06       Impact factor: 6.627

2.  Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia.

Authors:  J B Davis; J Gray; M J Gunthorpe; J P Hatcher; P T Davey; P Overend; M H Harries; J Latcham; C Clapham; K Atkinson; S A Hughes; K Rance; E Grau; A J Harper; P L Pugh; D C Rogers; S Bingham; A Randall; S A Sheardown
Journal:  Nature       Date:  2000-05-11       Impact factor: 49.962

3.  Topical capsaicin in the management of HIV-associated peripheral neuropathy.

Authors:  J A Paice; C E Ferrans; F R Lashley; S Shott; V Vizgirda; D Pitrak
Journal:  J Pain Symptom Manage       Date:  2000-01       Impact factor: 3.612

4.  Membrane potential oscillations in dorsal root ganglion neurons: role in normal electrogenesis and neuropathic pain.

Authors:  R Amir; M Michaelis; M Devor
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

5.  Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study.

Authors:  B S Galer; M C Rowbotham; J Perander; E Friedman
Journal:  Pain       Date:  1999-04       Impact factor: 6.961

6.  Cutaneous innervation density in the allodynic form of postherpetic neuralgia.

Authors:  M C Rowbotham; G Yosipovitch; M K Connolly; D Finlay; G Forde; H L Fields
Journal:  Neurobiol Dis       Date:  1996       Impact factor: 5.996

7.  Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes: a randomized, double-blind, placebo-controlled trial.

Authors:  Mary E Lynch; Alexander J Clark; Jana Sawynok; Michael J L Sullivan
Journal:  Anesthesiology       Date:  2005-07       Impact factor: 7.892

8.  A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia.

Authors:  C P Watson; K L Tyler; D R Bickers; L E Millikan; S Smith; E Coleman
Journal:  Clin Ther       Date:  1993 May-Jun       Impact factor: 3.393

9.  Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial.

Authors:  R Y Yuan; J J Sheu; J M Yu; W T Chen; I J Tseng; H H Chang; C J Hu
Journal:  Neurology       Date:  2009-02-25       Impact factor: 9.910

10.  Postherpetic neuralgia: topical lidocaine is effective in nociceptor-deprived skin.

Authors:  Gunnar Wasner; Anne Kleinert; Andreas Binder; Jörn Schattschneider; Ralf Baron
Journal:  J Neurol       Date:  2005-03-23       Impact factor: 6.682

View more
  3 in total

1.  [Chili for therapy of trigeminus neuralgia: a case report].

Authors:  J Loeser; B Pilgram; O Dagtekin
Journal:  Schmerz       Date:  2012-08       Impact factor: 1.107

2.  Outcome predictors for treatment success with 5% lidocaine medicated plaster in low back pain with neuropathic components and neuropathic pain after surgical and nonsurgical trauma.

Authors:  Andrew Nicolaou; Bruce Nicholson; Guy Hans; Louis Brasseur
Journal:  J Pain Res       Date:  2011-01-11       Impact factor: 3.133

3.  Platinum-Based Drugs Cause Mitochondrial Dysfunction in Cultured Dorsal Root Ganglion Neurons.

Authors:  Markus Leo; Linda-Isabell Schmitt; Patricia Küsterarent; Andrea Kutritz; Tienush Rassaf; Christoph Kleinschnitz; Ulrike B Hendgen-Cotta; Tim Hagenacker
Journal:  Int J Mol Sci       Date:  2020-11-16       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.